Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]
-
* Corresponding author: Andreas Karabinis akarab@ath.forthnet.gr
Critical Care 2004, 8:R268-R280 doi:10.1186/cc2896
Accesses
- Last 30 days: 52 accesses
- Last year: 833 accesses
- All time: 8792 accesses
Cited by
BioMed Central: 6 citations
|
Research
The incidence of sub-optimal sedation in the ICU: a systematic review Daniel L Jackson, Clare W Proudfoot, Kimberley F Cann, Tim S Walsh Critical Care 2009, 13:R204 (16 December 2009) |
|
Review
The place for short-acting opioids: special emphasis on remifentanil Wolfram Wilhelm, Sascha Kreuer Critical Care 2008, 12(Suppl 3):S5 (14 May 2008) |
|
Review
Medications for analgesia and sedation in the intensive care unit: an overview Diederik Gommers, Jan Bakker Critical Care 2008, 12(Suppl 3):S4 (14 May 2008) |
|
Research
Bernd Muellejans, Thomas Matthey, Joachim Scholpp, Markus Schill Critical Care 2006, 10:R91 (15 June 2006) |
|
Commentary
Narcotic-based sedation regimens for critically ill mechanically ventilated patients Pratik Pandharipande, E Wesley Ely Critical Care 2005, 9:247-248 (18 April 2005) |
|
Research
Des Breen, Andreas Karabinis, Manu Malbrain, Rex Morais, Sven Albrecht, Inge-Lise Jarnvig, Pauline Parkinson, Andrew JT Kirkham Critical Care 2005, 9:R200-R210 (15 March 2005) |